Royce & Associates LP Sells 67,260 Shares of Ingevity Corporation $NGVT

Royce & Associates LP reduced its position in shares of Ingevity Corporation (NYSE:NGVT) by 6.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,032,099 shares of the company’s stock after selling 67,260 shares during the period. Ingevity accounts for approximately 0.6% of Royce & Associates LP’s holdings, making the stock its 23rd biggest position. Royce & Associates LP’s holdings in Ingevity were worth $56,962,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Amalgamated Bank boosted its holdings in Ingevity by 1.7% during the third quarter. Amalgamated Bank now owns 10,593 shares of the company’s stock valued at $585,000 after acquiring an additional 180 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in shares of Ingevity by 3.1% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 7,823 shares of the company’s stock worth $418,000 after purchasing an additional 238 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Ingevity by 15.7% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,870 shares of the company’s stock valued at $103,000 after purchasing an additional 254 shares during the period. Savant Capital LLC boosted its stake in Ingevity by 0.4% during the 2nd quarter. Savant Capital LLC now owns 85,335 shares of the company’s stock valued at $3,677,000 after purchasing an additional 313 shares during the period. Finally, Range Financial Group LLC grew its holdings in Ingevity by 1.2% in the 3rd quarter. Range Financial Group LLC now owns 31,139 shares of the company’s stock valued at $1,719,000 after buying an additional 376 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on NGVT shares. BMO Capital Markets raised their price objective on shares of Ingevity from $64.00 to $70.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Jefferies Financial Group reissued a “buy” rating and issued a $82.00 price target on shares of Ingevity in a report on Thursday. Wall Street Zen upgraded shares of Ingevity from a “buy” rating to a “strong-buy” rating in a report on Sunday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research report on Thursday, January 22nd. Finally, Zacks Research raised Ingevity to a “hold” rating in a research report on Tuesday, December 16th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $75.67.

Ingevity Trading Up 2.0%

Shares of NGVT stock opened at $71.95 on Friday. Ingevity Corporation has a 52-week low of $28.49 and a 52-week high of $77.46. The stock has a market cap of $2.59 billion, a price-to-earnings ratio of -15.47 and a beta of 1.34. The company has a debt-to-equity ratio of 8.39, a quick ratio of 0.80 and a current ratio of 1.27. The firm has a fifty day moving average of $67.23 and a 200-day moving average of $59.16.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, February 25th. The company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.74 by ($0.16). The business had revenue of $255.10 million for the quarter, compared to analyst estimates of $257.27 million. Ingevity had a negative net margin of 13.51% and a positive return on equity of 100.39%. Ingevity’s revenue was down 3.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.95 earnings per share. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. On average, equities research analysts forecast that Ingevity Corporation will post 4.45 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.